Interim considerations : Preparing for the potential management of anaphylaxis after COVID-19 vaccination
Supporting Files
Public Domain
-
03/01/2021
File Language:
English
Details
-
Corporate Authors:
-
Description:A serious allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of a COVID-19 vaccine or an immediate allergic reaction of any severity after a previous dose or known (diagnosed) allergy to a component of a COVID-19 vaccine are contraindications to vaccination.
03/01/2021 CS321629-G
IntermConsid-Anaphylaxis-covid19-vaccine-sites.pdf
-
Content Notes:Overview -- Personnel, medications, and supplies for assessing and managing anaphylaxis -- Routine observation periods following COVID-19 vaccination -- Early recognition of anaphylaxis -- Management of anaphylaxis at a COVID-19 vaccination location -- Considerations for anaphylaxis management in special populations -- Patient counseling -- Reporting anaphylaxis -- Additional resources -- References -- Previous Updates.
-
Subjects:
-
Document Type:
-
Pages in Document:3 unumbered pages
-
Collection(s):
-
Main Document Checksum:urn:sha256:9e105f0b7b248df73bf12e1c4f83b81d4fe470e048669fd2bcf2ca8b86596db7
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Stephen B. Thacker CDC Library